Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...

Background: Acute myeloid leukemia ... initiating an anti-leukemia response. In addition, increased immune checkpoint activity implies activation of immunosuppressive pathways, further suppressing ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Refractory Acute Myeloid Leukemia.

Here are nine tips to help you manage chronic lymphocytic leukemia (CLL) and prevent it from disrupting your daily routine. Getting a cancer diagnosis often means starting treatment right away.

Chronic Myelogenous Leukemia Tyrosine kinase inhibitors (TKIs, a type of targeted therapy) have revolutionized the treatment of chronic myelogenous leukemia (CML) and resulted in a dramatic ...

Gingival hyperplasia and leukemic infiltration of the skin (leukemia cutis ... peripheral smear often reveal pancytopenia and immature myeloid cells. Some of the blast cells may contain Auer ...

How would you manage her leg symptoms? Chronic venous insufficiency manifests as a spectrum of signs and symptoms, including varicose veins, leg swelling, skin changes, and leg ulcers. The ...

Recently recognized by the World Health Organization, acute myeloid leukemia (AML ... subtype may express varying fusion transcripts and translocation breakpoints, the subtype is homogenous ...

Leukemia cutis is a relatively rare skin condition that’s caused by leukemia itself. It is typically seen with advanced leukemia or a form of the disease called acute myeloid leukemia (AML). Only ...